HK1250981A1 - 作為jak抑制劑的吡咯並嘧啶化合物的結晶 - Google Patents

作為jak抑制劑的吡咯並嘧啶化合物的結晶

Info

Publication number
HK1250981A1
HK1250981A1 HK18110261.1A HK18110261A HK1250981A1 HK 1250981 A1 HK1250981 A1 HK 1250981A1 HK 18110261 A HK18110261 A HK 18110261A HK 1250981 A1 HK1250981 A1 HK 1250981A1
Authority
HK
Hong Kong
Prior art keywords
crystallization
jak inhibitors
pyrrolopyrimidine compounds
pyrrolopyrimidine
compounds
Prior art date
Application number
HK18110261.1A
Other languages
English (en)
Inventor
周舟
張愛明
張喜全
姚華東
Original Assignee
正大天晴藥業集團股份有限公司
連云港潤眾制藥有限公司
北京賽林泰醫藥技術有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 正大天晴藥業集團股份有限公司, 連云港潤眾制藥有限公司, 北京賽林泰醫藥技術有限公司 filed Critical 正大天晴藥業集團股份有限公司
Priority to HK18110261.1A priority Critical patent/HK1250981A1/zh
Publication of HK1250981A1 publication Critical patent/HK1250981A1/zh

Links

HK18110261.1A 2018-08-10 2018-08-10 作為jak抑制劑的吡咯並嘧啶化合物的結晶 HK1250981A1 (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HK18110261.1A HK1250981A1 (zh) 2018-08-10 2018-08-10 作為jak抑制劑的吡咯並嘧啶化合物的結晶

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HK18110261.1A HK1250981A1 (zh) 2018-08-10 2018-08-10 作為jak抑制劑的吡咯並嘧啶化合物的結晶

Publications (1)

Publication Number Publication Date
HK1250981A1 true HK1250981A1 (zh) 2019-01-18

Family

ID=71453024

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18110261.1A HK1250981A1 (zh) 2018-08-10 2018-08-10 作為jak抑制劑的吡咯並嘧啶化合物的結晶

Country Status (1)

Country Link
HK (1) HK1250981A1 (zh)

Similar Documents

Publication Publication Date Title
IL263429A (en) Crystalline forms of a triazolopyrimidine compound
HUE053463T2 (hu) Pirrolopirimidin vegyületek, amelyek használhatók JAK inhibitorokként
HK1245770A1 (zh) 尿嘧啶化合物的新型結晶
IL274037A (en) A pyrimidine compound as a JAK kinase inhibitor
EP3619208C0 (en) CRYSTALLINE FORMS OF A JAK INHIBITOR COMPOUND
IL304110A (en) Keap1–nrf2 protein–protein interaction inhibitors
EP3766529A4 (en) COMPOSITION FOR PURIFICATION OF BIOFLUIDS
IL287717A (en) Pyrrolopyridines are converted as jak inhibitors
EP3473626A4 (en) PYRROLOPYRIMIDINE CRYSTAL FOR PRODUCING JAK INHIBITORS
AU2017260854B2 (en) Enhancer of Zeste Homolog 2 inhibitors
IL276312B1 (en) Use of Alkoxypyrazoles as nitrification inhibitors
IL269695A (en) Compounds useful as ALCAT 1 inhibitors
IL269073A (en) Crystalline forms of obeticholic acid
IL285219A (en) A crystal of the compound diarylthiohydantoin
IL277869A (en) Substituted propanamides as nuclease inhibitors
HK1250981A1 (zh) 作為jak抑制劑的吡咯並嘧啶化合物的結晶
IL277578A (en) New salt forms of URAT-1 inhibitors
EP3315493A4 (en) PHENYLAMINOPYRIMIDINE COMPOUND OR POLYMORPH THEREOF
IL277866B1 (en) Aminothiazoles were substituted as nuclease inhibitors
GB201912411D0 (en) Crystalline forms of ivosidenib
PL3826983T3 (pl) Zastosowanie podstawionych 2-tiazolin jako inhibitorów nitryfikacji
GB201804905D0 (en) Cataltic synthesis of biarylic compounds
EP3494105A4 (en) COMPOUNDS USED AS SODIUM CHANNEL INHIBITORS
GB201915908D0 (en) Crystalline forms of entrectinib
GB201910665D0 (en) Novel form of compounds